In the Satiety and Clinical AdiposityLiraglutide Evidence (SCALE) Diabetes trial, a total of 846 overweight and obese patients with T2D were randomly assigned to receive 3.0 or 1.8 mg of liraglutide or placebo for 56 weeks
doi: 10.1016/S0140-6736(21)00213-0 100 WildingJPHBatterhamRLCalannaSDaviesMVan GaalLFLingvayIet al
That said, GLP-1 users report snacking more in between meals than Americans who share a similar demographic distribution (by age and gender) but are not using GL-1 medications
But first, youll need to know how to inject it
The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes
These medications work by mimicking the natural GLP-1 hormone, which plays a crucial role in regulating blood sugar, controlling appetite, and improving insulin sensitivity